Form 13-F position report

SUTRO BIOPHARMA INC

Reported by Balyasny Asset Management LLC

STRO CUSIP 869367201 Manager CIK 0001218710

Reported 223,114 shares, down 488,048 (68.6%) from the prior quarter.

Reported value -84.8%; share count -68.6% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q3 2026
Shares 223,114 Quarter-end amount reported
Reported value $3,594,367 Fair value at quarter end
Consecutive quarters held 4 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-12-31 2661667
2026-03-31 11602879
2026-06-30 23610578
2026-09-30 3594367

Quarterly position history

How this manager's reported quarter-end position changed over time.

4 quarters
Quarterly reported position history for SUTRO BIOPHARMA INC held by Balyasny Asset Management LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 223,114 -488,048 (-68.6%) < 0.01% $3,594,367 2026-11-16
Q2 2026 Added 711,162 +245,370 (52.7%) 0.03% $23,610,578 2026-08-14
Q1 2026 Added 465,792 +235,743 (102.5%) 0.02% $11,602,879 2026-05-15
Q4 2025 New 230,049 +230,049 (0.0%) < 0.01% $2,661,667 2026-02-17

Who else reported the position

115 managers reported SUTRO BIOPHARMA INC for Q3 2026.

Managers reporting SUTRO BIOPHARMA INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BVF INC IL Unchanged 1,251,788 0 0.66% $20,166,305 3 qtrs
BlackRock Inc Added 1,178,196 +55,541 < 0.01% $18,980,738 4 qtrs
Affinity Asset Advisors LLC Reduced 1,152,487 -20,000 0.76% $18,566,566 4 qtrs
Samsara BioCapital LLC Unchanged 1,062,872 0 1.63% $17,122,868 4 qtrs
PERCEPTIVE ADVISORS LLC Reduced 970,846 -334,000 0.27% $15,640,329 3 qtrs
Kynam Capital Management LP Unchanged 872,558 0 0.78% $14,056,909 4 qtrs
ORBIMED ADVISORS LLC Unchanged 743,944 0 0.22% $11,984,938 3 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Reduced 676,926 -17,293 < 0.01% $10,905,278 3 qtrs
ACADIAN ASSET MANAGEMENT LLC Added 557,868 +184,029 0.01% $8,977,000 4 qtrs
Velan Capital Investment Management LP Reduced 510,038 -2,122 7.84% $8,216,712 4 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
COM SHS

Voting authority reported

Sole
223,114
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.